Gangrena de Fournier: Estudio retrospectivo de 41 casos

Barreda, Jose Torremadé; Scheiding, Mónica Millán; Fernández, Cristina Suárez; Campaña, José María Cuadrado; Aguilera, José Rodríguez; Miranda, Eladio Franco; Biondo, Sebastiano

doi:10.1016/j.ciresp.2009.12.012

Cited by 26 publications

(5 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…9,12,[14][15][16][17][18] The CCI and AACCI have been recently described as mortality predictive factors, as it occurred in our series. 1,7-10 Multiple predictive factors have been described.…”

Section: Discussionsupporting

confidence: 65%

Predictive Factors for Mortality in Fournier's Gangrene: A Series of 59 Cases

Marín

Fuentes

Ayuso

et al. 2015

Cirugía Española (English Edition)

View full text Add to dashboard Cite

Section: Discussionsupporting

confidence: 65%

Predictive Factors for Mortality in Fournier's Gangrene: A Series of 59 Cases

Marín

Fuentes

Ayuso

et al. 2015

Cirugía Española (English Edition)

View full text Add to dashboard Cite

“…It has been shown in various studies that diabetes mellitus is the most important etiological factor. 26,27 In our study, diabetes was detected in 64.3% of the patients. Although diabetes is a risk factor in etiology, its effect on mortality could not be demonstrated as we have shown in our study (P = .22).…”

Section: Discussionsupporting

confidence: 51%

Effect of Sarcopenia on Mortality and Morbidity in Patients With Fournier’s Gangrene

Tazeoğlu

Benli

Esmer

et al. 2023

The American Surgeon™

View full text Add to dashboard Cite

Background Preoperative sarcopenia is an essential factor that negatively affects postoperative results. The effect of preoperative sarcopenia on postoperative complications and prognosis in patients treated for Fournier’s gangrene (FG) is controversial. This retrospective cohort study analyzed the effect of FG to evaluate the effect of preoperative sarcopenia on postoperative complications and prognosis in patients who were operated on. Method The data of patients who were operated on with FG diagnosis in our clinic between 2008 and 2020 were reviewed retrospectively. Demographic data (age and gender), anthropometric measurements, preoperative laboratory values, abdominopelvic CT, location of FG, number of debridements, ostomy, microbiological culture result, wound closure method, length of hospital stay, and overall survival were recorded. In addition, the presence of sarcopenia was determined according to psoas muscular index (PMI) and Hounsfield unit average calculation (HUAC). Results Of the patients, 57 (30.8%) were female and 128 (69.2%) were male. According to the PMI, sarcopenia was detected in 67 (36.2%) patients and 70 (37.8%), according to the HUAC. At the end of one postoperative year, the mortality rate was higher in the sarcopenia group than in the non-sarcopenia group (P = .002, P = .01). According to the PMI, patients with sarcopenia have an 8.17 times greater risk of exitus than non-sarcopenic patients. According to the HUAC, patients with sarcopenia have a 4.21 times greater risk of exitus than non-sarcopenic patients. Conclusion Based on this large retrospective study, sarcopenia is a strong and independent predictor of postoperative mortality after Fournier’s treatment for gangrene.

show abstract

“…Despite all the current therapeutic advances, FS continues to present prolonged hospitalization and high mortality rates. Death can occur in patients with prolonged disease, spread of infection and lung involvement, which can be predicted by clinical follow-up and evidence of sepsis [17][18]. In this study, the mean hospital stay was longer than 19 days and 22.5% of the patients died.…”

Section: Discussionmentioning

confidence: 59%

Profile of Patients With Fournier's Syndrome Treated in a Public Hospital in The: Oeste Do Paraná

Santos¹,

Cipriani²,

Costa³

2022

JHSR

View full text Add to dashboard Cite

Goal:To analyze the profile of patients with DES treated in a tertiary public hospital in Oeste do Paraná. Methods: A cross-sectional, retrospective and descriptive study was carried out based on the analysis of medical records of patients with FS from January 2012 to November 2016. Results: 40 patients with DES were treated in the period: 29 (72.5%) men and 11 (27.5%) women. The mean age was 51.7 ±16.3 years. The mean time of disease evolution, from the initial symptom to admission to the service, was 10.5 ± 1.2 days. All patients had some clinical sign such as pain, bulging, erythema, among others, and associated comorbidities (38 patients -95%), the most common being type II diabetes mellitus (DM) and systemic arterial hypertension (SAH). The majority (30 patients -75%) had a probable etiology of perianal abscess. All patients underwent antibiotic therapy and surgical treatment with a mean of 1.8 ± 1.1 surgeries/patient. Nine (22.5%) patients died. There was a strong correlation between the presence of sepsis on admission and mortality. Conclusion: Patients with FS in this series had a long time of disease and a high prevalence of comorbidities. It is possible that improvements in the basic health system, with control of underlying chronic diseases and early referral to a specialist, improve the prognosis of these patients.

show abstract

Gangrena de Fournier: Estudio retrospectivo de 41 casos

Cited by 26 publications

References 30 publications

Predictive Factors for Mortality in Fournier's Gangrene: A Series of 59 Cases

Predictive Factors for Mortality in Fournier's Gangrene: A Series of 59 Cases

Effect of Sarcopenia on Mortality and Morbidity in Patients With Fournier’s Gangrene

Profile of Patients With Fournier's Syndrome Treated in a Public Hospital in The: Oeste Do Paraná

Contact Info

Product

Resources

About